Your browser doesn't support javascript.
loading
Lymphoceles after pelvic lymph node dissection during robot-assisted radical prostatectomy.
Meenderink, Jonas J L; Kroon, Lisa J; van der Slot, Margaretha A; Venderbos, Lionne D F; van Leenders, Geert J L H; Roobol, Monique J; Busstra, Martijn B.
Afiliación
  • Meenderink JJL; Department of Urology, Erasmus MC Cancer Institute, Erasmus MC, Rotterdam, The Netherlands.
  • Kroon LJ; Department of Urology, Erasmus MC Cancer Institute, Erasmus MC, Rotterdam, The Netherlands.
  • van der Slot MA; Department of Urology, Maasstad Hospital, Rotterdam, The Netherlands.
  • Venderbos LDF; Anser Prostate Operation Clinic, Rotterdam, The Netherlands.
  • van Leenders GJLH; Department of Pathology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
  • Roobol MJ; Department of Urology, Maasstad Hospital, Rotterdam, The Netherlands.
  • Busstra MB; Anser Prostate Operation Clinic, Rotterdam, The Netherlands.
Transl Androl Urol ; 12(11): 1622-1630, 2023 Nov 30.
Article en En | MEDLINE | ID: mdl-38106676
ABSTRACT

Background:

Lymphoceles, lymph fluid-filled collections within the body lacking epithelial lining, are a common complication after pelvic lymph node dissection (PLND) during robot-assisted radical prostatectomy (RARP). In this study, we investigate the incidence of imaging confirmed symptomatic lymphoceles (SLC) in a centralized high-volume operating centre and assess predictive factors and treatment.

Methods:

We retrospectively analysed the incidence, risk factors and treatment of a consecutive series of patients who underwent PLND during RARP between September 2018 and January 2021 in a specialised operation clinic. We compared baseline patients' characteristics and pathological data between men who developed an SLC and those who did not. A multivariable model for the occurrence of an SLC was created using predetermined, clinically relevant variables to investigate predictive factors.

Results:

We analysed the records of 404 patients. The median follow-up length was 29 months. A total of 30 (7.4%) patients with an SLC were identified. The median time until SLC presentation was 12 weeks [interquartile range (IQR), 4-31 weeks], one-third of SLCs presented after 180 days. Percutaneous drainage was performed in 17 patients (57%). On multivariable analysis, only body mass index (BMI) significantly increased the odds of an SLC [per 5 odds ratio (OR) =1.7; 95% confidence interval (CI) 1.0-3.0, P=0.04].

Conclusions:

SLCs present significant consequences, as more than half of patients with an SLC were treated with percutaneous drainage. Many patients presented later than the centralized surgeons' postoperative follow-up, a drawback of centralized care. An increased BMI was a significant predictor for SLC.
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Transl Androl Urol Año: 2023 Tipo del documento: Article País de afiliación: Países Bajos Pais de publicación: China
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Transl Androl Urol Año: 2023 Tipo del documento: Article País de afiliación: Países Bajos Pais de publicación: China